This information was published on 2026-03-11T15:33:54 for IP Right Filed Published.
| Field | Value |
| (210) | 2634459 |
| (220) |
11 Mar 2026
|
| (300) |
US, 03 Nov 2025, 99/475,902
|
| (511) (510) |
Class 5
Pharmaceutical preparations for the treatment of auditory, hematological, gastrointestinal, neuromuscular, muscular, cardiovascular, metabolic, immunological, inflammatory, oncological, ophthalmological, neurological, musculoskeletal, bone, connective tissue, dermatological, infectious, autoimmune, nephrological, hepatological, allergic, genetic, respiratory, viral, and pulmonary diseases and disorders; pharmaceutical preparations for the treatment of pain; pharmaceutical preparations for the treatment of obesity; pharmaceutical preparations for immunotherapy treatment, cell therapy, and gene therapy |
| (540) | POSAFYVE |
| (550) | Word |
| (730) |
Regeneron Pharmaceuticals, Inc.
|
| (750) |
PHILLIPS ORMONDE FITZPATRICK
|
Find out more about publications on the About page.